KEWPIE CORP
Overview
KEWPIE CORP is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering HYALURONSAN HA-AM (SODIUM HYALURONATE); HYALURONSAN HA-AML(SODIUM HYALURONATE) DRUG SUBSTANCE; HYALURONSAN HA-SHL (SODIUM HYALURONATE).
API / Drug Master Files
KEWPIE CORP holds 3 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- HYALURONSAN HA-SHL (SODIUM HYALURONATE)Active2018-12-31
- HYALURONSAN HA-AML(SODIUM HYALURONATE) DRUG SUBSTANCEActive2016-04-22
- HYALURONSAN HA-AM (SODIUM HYALURONATE)Active2000-02-29
- ETHYL ICOSAPENTATE DRUG SUBSTANCEInactive2016-06-01
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to KEWPIE CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this KEWPIE CORP? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.